1. Home
  2. AKRO vs ANF Comparison

AKRO vs ANF Comparison

Compare AKRO & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • ANF
  • Stock Information
  • Founded
  • AKRO 2017
  • ANF 1892
  • Country
  • AKRO United States
  • ANF United States
  • Employees
  • AKRO N/A
  • ANF N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • ANF Clothing/Shoe/Accessory Stores
  • Sector
  • AKRO Health Care
  • ANF Consumer Discretionary
  • Exchange
  • AKRO Nasdaq
  • ANF Nasdaq
  • Market Cap
  • AKRO 4.5B
  • ANF 3.8B
  • IPO Year
  • AKRO 2019
  • ANF 1996
  • Fundamental
  • Price
  • AKRO $54.34
  • ANF $70.50
  • Analyst Decision
  • AKRO Buy
  • ANF Buy
  • Analyst Count
  • AKRO 10
  • ANF 10
  • Target Price
  • AKRO $73.56
  • ANF $103.60
  • AVG Volume (30 Days)
  • AKRO 1.7M
  • ANF 1.5M
  • Earning Date
  • AKRO 11-07-2025
  • ANF 11-25-2025
  • Dividend Yield
  • AKRO N/A
  • ANF N/A
  • EPS Growth
  • AKRO N/A
  • ANF 13.04
  • EPS
  • AKRO N/A
  • ANF 10.58
  • Revenue
  • AKRO N/A
  • ANF $5,099,754,000.00
  • Revenue This Year
  • AKRO N/A
  • ANF $7.57
  • Revenue Next Year
  • AKRO N/A
  • ANF $3.98
  • P/E Ratio
  • AKRO N/A
  • ANF $6.58
  • Revenue Growth
  • AKRO N/A
  • ANF 9.34
  • 52 Week Low
  • AKRO $21.34
  • ANF $65.40
  • 52 Week High
  • AKRO $58.40
  • ANF $164.80
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 68.92
  • ANF 41.84
  • Support Level
  • AKRO $54.10
  • ANF $68.37
  • Resistance Level
  • AKRO $54.37
  • ANF $72.54
  • Average True Range (ATR)
  • AKRO 0.18
  • ANF 2.40
  • MACD
  • AKRO -0.22
  • ANF 0.46
  • Stochastic Oscillator
  • AKRO 89.00
  • ANF 43.66

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About ANF Abercrombie & Fitch Company

Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.

Share on Social Networks: